Trial Profile
Supersaturation and precipitation of tacrolimus in the stomach of healthy volunteers.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 17 Oct 2022
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Allergic conjunctivitis; Atopic dermatitis; Coronary artery restenosis; Eye disorders; Graft-versus-host disease; Interstitial lung diseases; Intestinal transplant rejection; Lupus nephritis; Myasthenia gravis; Open-angle glaucoma; Psoriasis; Rheumatoid arthritis; Transplant rejection; Ulcerative colitis
- Focus Pharmacokinetics
- 16 Oct 2022 Status changed from recruiting to discontinued.
- 12 Aug 2017 New trial record